Pfizer Files Lawsuit Alleging J&J Thwarted Use of Biosimilar Rival to Remicade

Pfizer Inc. filed suit against Johnson & Johnson alleging it has thwarted biosimilar competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced copy.

from WSJ.com: US Business http://ift.tt/2hgQqaP
via IFTTT